{
  "meta": {
    "title": "Hemoglobinopathies",
    "url": "https://brainandscalpel.vercel.app/hemoglobinopathies-61cf5a8d.html",
    "scrapedAt": "2025-11-29T18:32:00.701Z"
  },
  "questions": [
    {
      "id": 14272,
      "choices": [
        {
          "id": 57049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia major</span></span></span></p>"
        },
        {
          "id": 57050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia minor</span></span></span></p>"
        },
        {
          "id": 57051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span>​</p>"
        },
        {
          "id": 57052,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?</span></span></span></p>",
      "unique_key": "Q8775889",
      "question_audio": null,
      "question_video": null,
      "map_id": 31928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Thalassemia minor </span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia major </strong>patient presents with <strong>severe anemia and cannot survive without blood transfusion, </strong>so this option can be easily ruled out. For other options, <strong>Mentzer index </strong>is useful for <strong>differentiating between thalassemia minor and iron deficiency anemia. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia minor </strong>often presents with <strong>mild to moderate anemia </strong>and a <strong>low MCV. </strong>The <strong>Mentzer index</strong>, calculated as <strong>MCV </strong>divided by the <strong>RBC count</strong>, is less than <strong>13 in thalassemia minor.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patients with thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>major </strong>typically present with <strong>severe anemia</strong> requiring regular<strong> blood transfusions. </strong>The degree of anemia in the <strong>vignette</strong> is not consistent with thalassemia major.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with<strong> microcytic and hypochromic anemia</strong>. The<strong> Mentzer index </strong>is generally <strong>greater than 13</strong>, which is not the case here.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with <strong>normocytic or sometimes microcytic anemia</strong>, but it is often characterized by a<strong> normal or increased storage iron level</strong>, which can be evaluated by <strong>serum ferritin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When presented with<strong> mild to moderate microcytic anemia </strong>and an <strong>MCV/RBC count </strong>that yields a <strong>Mentzer index of less than 13, thalassemia minor </strong>is a likely diagnosis. </span></span></p>",
      "correct_choice_id": 57050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14268,
      "choices": [
        {
          "id": 57033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia trait</span></span></span></p>"
        },
        {
          "id": 57034,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 57035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditory spherocytosis</span></span></span></p>"
        },
        {
          "id": 57036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6 PD deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?</span></span></span></span></span></p>",
      "unique_key": "Q9765507",
      "question_audio": null,
      "question_video": null,
      "map_id": 31936,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Beta thalassemia trait </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Beta thalassemia trait is characterized by a mutation in the beta-globin gene, leading to reduced (&beta;+) or absent (&beta;0) production of &beta;-globin chains. Compensatory increase in HbA2 (&alpha;2&delta;2) is a hallmark of this condition.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Hemoglobin electrophoresis usually reveals an increase in HbA2 (&alpha;2&delta;2) to 4% to 8% of the total hemoglobin (nor&not;mal, 2.5% &plusmn; 0.3%), which is a reflection of an elevated ra&not;tio of &delta;-chain to &beta;-chain synthesis. HbF levels are generally normal or occasionally slightly increased</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Sickle cell anemia</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Hereditary spherocytosis</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. G6PD deficiency</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<em> Robbins 10<sup>th</sup>/ 641 </em></span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
      "correct_choice_id": 57033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41786,
      "choices": [
        {
          "id": 166828,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 4 alpha chains</span></span></span></p>"
        },
        {
          "id": 166829,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 3 alpha chains</span></span></span></p>"
        },
        {
          "id": 166830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 2 alpha chains</span></span></span></p>"
        },
        {
          "id": 166831,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 1 alpha chain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbH is formed due to which of the following? </span></span></span></p>",
      "unique_key": "Q8500792",
      "question_audio": null,
      "question_video": null,
      "map_id": 31934,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Deletion of 3 alpha chains </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of 3 alpha chains </strong>leads to the formation of<strong> HbH disease</strong>. HbH is composed of<strong> four beta-globin chains </strong>and is formed in response to the lack of sufficient<strong> alpha chains</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of all 4 alpha chains </strong>typically results in<strong> hydrops fetalis </strong>and is usually<strong> incompatible with life</strong>; hence it does not lead to the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of 1</strong> <strong>alpha chain </strong>usually causes no significant clinical symptoms and is known as <strong>silent carrier state</strong>; it does not lead to HbH formation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C: Deletion of 2</strong> <strong>alpha chains </strong>often causes a milder form of<strong> alpha thalassemia, </strong>known as<strong> alpha thalassemia trait or alpha thalassemia minor</strong>, not typically associated with the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HbH disease </strong>is caused by the <strong>deletion of three alpha-globin genes</strong>, which leads to an <strong>excess of beta-globin chains </strong>that form the <strong>abnormal hemoglobin H (beta4).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 645 </span></em></strong></span></span></p>",
      "correct_choice_id": 166829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41787,
      "choices": [
        {
          "id": 166832,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stability</span></span></span></p>"
        },
        {
          "id": 166833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Function</span></span></span></p>"
        },
        {
          "id": 166834,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affinity</span></span></span></p>"
        },
        {
          "id": 166835,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solubility</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is affected in sickled hemoglobin; HbS? </span></span></span></p>",
      "unique_key": "Q5216378",
      "question_audio": null,
      "question_video": null,
      "map_id": 31935,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Solubility </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Solubility </strong>is the property most affected by the <strong>mutation causing HbS</strong>. Under<strong> deoxygenated </strong>conditions,<strong> HbS polymerizes, </strong>leading to the formation of<strong> insoluble fibers </strong>that deform the <strong>red blood cells into a sickle shape</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stability</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to the <strong>hemoglobin molecule&#39;s resistance to denaturation and degradation</strong>. While HbS can be less stable under deoxygenating conditions, this is not the primary issue.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option B. Function pertains</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the <strong>ability </strong>of hemoglobin to<strong> carry oxygen</strong>. HbS can still <strong>carry oxygen</strong>, but the sickling process can hinder its release to tissues.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Affinity refers</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the<strong> hemoglobin&#39;s ability </strong>to<strong> bind oxygen</strong>. <strong>HbS </strong>has a <strong>slightly different oxygen</strong> affinity compared to normal hemoglobin, but again, this is not the main problem.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell hemoglobin (HbS) </strong>is primarily characterized by <strong>reduced solubility </strong>under<strong> deoxygenated </strong>conditions, leading to <strong>polymerization and sickling </strong>of red blood cells. This results in<strong> vaso-occlusive crises and chronic hemolytic anemia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 638</span></span></em></strong></p>",
      "correct_choice_id": 166835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41782,
      "choices": [
        {
          "id": 166812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha thalassemia</span></span></span></p>"
        },
        {
          "id": 166813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia</span></span></span></p>"
        },
        {
          "id": 166814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 166815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV &ndash; 30 fl, MCHC &ndash; 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient? </span></span></span></p>",
      "unique_key": "Q3311716",
      "question_audio": null,
      "question_video": null,
      "map_id": 31931,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Beta thalassemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Friends, let&rsquo;s get the answer of this question in a methodical manner. The clues in the question:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced values of MCV and MCHC:<strong> microcytic hypochromic anemia </strong>(G6PD deficiency is ruled out)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of presentation and ethnicity:<strong> 6-year-old and Punjabi ethnicity </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of <strong>repeated blood transfusion: </strong>in favour of <strong>thalassemia </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Osmotic fragility is reduced: </strong>in favour of thalassemia again though it may be seen in sickle cell also </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also, the hemoglobin is the question is more suggestive of <strong>severe anemia</strong> with<strong> positive</strong> <strong>history of multiple blood transfusions</strong> both being important pointers towards <strong>thalassemia major</strong>. Other ethnic groups having high prevalence of thalassemia are<strong> Punajbis, Sindhis, Gujaratis, Parsis, Begalis and Lohanas.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above-mentioned points point to thalassemia. Since<strong> beta thalassemia is more prevalent, </strong>it is&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a better option than alpha thalassemia. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with <strong>microcytic anemia </strong>and can be<strong> severe </strong>depending on the<strong> number of gene deletions </strong>but is less common in the Punjabi population.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sickle cell anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with<strong> normocytic anemia </strong>and not typically microcytic anemia. It can have target cells but is most commonly associated with the<strong> African population.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to<strong> hemolytic anemia,</strong> often episodic and related to <strong>oxidative stress,</strong> but it typically<strong> does not cause a microcytic hypochromic anemia or a reduced&nbsp;</strong></span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCV and MCHC.</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The&nbsp; presentation of s<strong>evere microcytic hypochromic anemia with target cells</strong>, a history of<strong> multiple blood transfusions,</strong> and <strong>reduced</strong> <strong>osmotic fragility</strong> in a child from an <strong>ethnicity with a high prevalence of thalassemia </strong>strongly suggests <strong>beta thalassemia major</strong> as the most likely diagnosis.</span></span></p>",
      "correct_choice_id": 166813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41785,
      "choices": [
        {
          "id": 166824,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of alpha genes</span></span></span></p>"
        },
        {
          "id": 166825,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of beta genes</span></span></span></p>"
        },
        {
          "id": 166826,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess of alpha genes</span></span></span></p>"
        },
        {
          "id": 166827,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single amino acid substitution in alpha chain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the cause of alpha thalassemia?</span></span></span></p>",
      "unique_key": "Q5794467",
      "question_audio": null,
      "question_video": null,
      "map_id": 31933,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Deletion of alpha genes </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of alpha genes </strong>is the primary cause of<strong> alpha thalassemia. </strong>The number of deleted genes can affect the<strong> severity of the disease</strong>; the<strong> loss of two genes </strong>causes mild disease, while the <strong>loss of all four genes leads to hydrops fetalis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Deletion of beta</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes leads to<strong> beta thalassemia. </strong>This condition results from <strong>mutations in the beta-globin gene </strong>on <strong>chromosome 11</strong>, not the alpha-globin gene on chromosome 16.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Excess of alpha</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes <strong>does not cause alpha thalassemia. </strong>Typically, an<strong> imbalance between alpha and beta chains </strong>due to a relative lack of<strong> alpha genes </strong>is what causes <strong>thalassemias.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Single amino</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> acid substitution in the<strong> alpha chain </strong>is commonly associated with hemoglobin variants like <strong>Hemoglobin C or S, </strong>but <strong>not with thalassemia</strong>, which is a<strong> quantitative problem with globin chain production.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha thalassemia </strong>is most commonly caused by the <strong>deletion of alpha genes on chromosome 16</strong>, which leads to a<strong> quantitative reduction </strong>in the production of <strong>alpha-globin chains.</strong></span></span></span></p>",
      "correct_choice_id": 166824,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41783,
      "choices": [
        {
          "id": 166816,
          "text": "<p><span style=\"font-size:12pt;\">β- thalassemia</span></p>"
        },
        {
          "id": 166817,
          "text": "<p><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 166818,
          "text": "<p><span style=\"font-size:12pt;\">Autoimmune haemolytic anaemia</span></p>"
        },
        {
          "id": 166819,
          "text": "<p><span style=\"font-size:12pt;\">Megaloblastic anaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">NESTROF test is a screening test for which of the following conditions?</span></p>",
      "unique_key": "Q9047769",
      "question_audio": null,
      "question_video": null,
      "map_id": 31932,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A.&nbsp;β- thalassemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>β-thalassemia</strong> - <strong>NESTROFT is</strong> used to<strong> screen for beta-thalassemia </strong>because red blood cells in this condition exhibit reduced<strong> fragility.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gpLLE9O.png\" width=\"968\" height=\"289\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>NESTROFT </strong>is a screening test for<strong> beta-thalassemia, </strong>which is based on the<strong> decreased osmotic fragility </strong>of red blood cells in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The NESTROFT test (Naked Eye Single Tube Red cell Osmotic Fragility Test) is a simple, cheap screening test used especially in countries like India to screen for β-thalassemia trait (carrier state).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">How it works:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Based on the principle that RBCs in thalassemia are microcytic and hypochromic → they have a reduced osmotic fragility (more resistant to lysis in hypotonic saline).</span></li><li><span style=\"font-size:12.0pt;\">In the test:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">A single hypotonic saline solution (usually around 0.36% NaCl) is used.</span></li><li><span style=\"font-size:12.0pt;\">After incubation, if the solution remains turbid → positive test (RBCs did not lyse → likely β-thalassemia trait).</span></li><li><span style=\"font-size:12.0pt;\">If the solution becomes clear → negative test (RBCs lysed → normal).</span></li></ul></li></ul>",
      "correct_choice_id": 166816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14275,
      "choices": [
        {
          "id": 57061,
          "text": "<p><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 57062,
          "text": "<p><span style=\"font-size:12pt;\">Thalassemia major</span></p>"
        },
        {
          "id": 57063,
          "text": "<p><span style=\"font-size:12pt;\">Thalassemia minor</span></p>"
        },
        {
          "id": 57064,
          "text": "<p><span style=\"font-size:12pt;\">Megaloblastic anemia</span>​​​​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30 years old female undergoes blood investigations which reveal RBC count 4.5 million, MCV 55fl and TLC 8000/mm3. There is no history of blood transfusion. What is the likely diagnosis?</span></p>",
      "unique_key": "Q3517952",
      "question_audio": null,
      "question_video": null,
      "map_id": 31929,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Thalassemia minor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Thalassemia minor (beta-thalassemia trait) </strong>typically presents with <strong>mild to moderate microcytic, hypochromic anemia </strong>and a <strong>normal or slightly elevated RBC count</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia</strong> (IDA) is characterized by<strong> microcytic, hypochromic red cells</strong>, often with a<strong> high RDW and low serum ferritin levels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Thalassemia major presents</strong> with <strong>severe microcytic anemia </strong>usually requiring <strong>blood transfusions for survival</strong>, often diagnosed in childhood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Megaloblastic anemia Megaloblastic</strong> anemia is characterized by <strong>macrocytosis </strong>with an <strong>MCV </strong>typically greater than <strong>100 fL due to impaired DNA synthesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a patient with <strong>microcytic anemia </strong>and <strong>an MCV of 55 fL, a normal TLC, </strong>and <strong>no history of transfusion, thalassemia minor </strong>is likely, particularly when using indices such as the<strong> Mentzer index (MCV/RBC count), </strong>which is <strong>less than 13 </strong>in thalassemia minor.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zwWMveA.png\" width=\"867\" height=\"238\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u> Robbins 10<sup>th</sup> 644</strong></span></p>",
      "correct_choice_id": 57063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41788,
      "choices": [
        {
          "id": 166836,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosplenectomy</span></p>"
        },
        {
          "id": 166837,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow expansion in the calvarium</span></p>"
        },
        {
          "id": 166838,
          "text": "<p><span style=\"font-size:12.0pt;\">Effective erythropoeisis</span></p>"
        },
        {
          "id": 166839,
          "text": "<p><span style=\"font-size:12.0pt;\">Predisposition to *Hemophilus influenzae *infections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following manifestations is common to sickle cell anemia and thalassemia major?</span></p>",
      "unique_key": "Q4381514",
      "question_audio": null,
      "question_video": null,
      "map_id": 31930,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Bone marrow expansion in the calvarium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bone marrow expansion in the calvarium is a response to the increased erythropoietic demand in both sickle cell anemia and thalassemia major. This compensatory mechanism for chronic anemia causes a characteristic radiographic appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. Autosplenectomy is the process of spleen shrinkage and fibrosis due to chronic damage, commonly seen in sickle cell anemia as a result of repeated vaso-occlusive episodes but is not a typical feature of thalassemia major.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Effective erythropoiesis refers to the production of functional red blood cells that successfully mature and enter circulation. This is not characteristic of either condition, as both sickle cell anemia and thalassemia major are marked by ineffective erythropoiesis resulting in inadequate functional red cell production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Predisposition to Hemophilus influenzae infections is more commonly associated with asplenic or hyposplenic individuals, but it is not directly related to the bone marrow changes seen on skull x-rays.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both sickle cell anemia and thalassemia major can lead to bone marrow expansion in the calvarium as a compensatory response to increased erythropoietic demand due to chronic hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Robbins 10th/ 640</span></p>",
      "correct_choice_id": 166837,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41789,
      "choices": [
        {
          "id": 166840,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell trait</span></span></span></p>"
        },
        {
          "id": 166841,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haemoglobin SC disease</span></span></span></p>"
        },
        {
          "id": 166842,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassaemia</span></span></span></p>"
        },
        {
          "id": 166843,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle &ndash;Hb E disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One of the common variants of sickle cell anemia frequently marked by lesser degree of haemolytic anemia and greater propensity for the development of retinopathy and aseptic necrosis of bones is: </span></span></span></p>",
      "unique_key": "Q1291495",
      "question_audio": null,
      "question_video": null,
      "map_id": 31937,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Sickle thalassaemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassaemia is one of the common variants of sickle cell anemia frequently marked by <strong>lesser degree of haemolytic anemia</strong> and <strong>greater propensity</strong> for the development of <strong>retinopathy and aseptic necrosis of bones</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassemia is a coinheritance of a sickle cell gene and a thalassemia gene. It can present with a variable clinical picture, often with a lesser degree of hemolytic anemia but can have complications such as retinopathy and aseptic necrosis of bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sickle cell trait</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, the heterozygous form of sickle cell disease, usually causes no symptoms or a very mild clinical course and does not typically lead to complications like retinopathy or aseptic necrosis of bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hemoglobin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SC disease is a compound heterozygous condition with one sickle cell gene and one gene for hemoglobin C. It can present with a clinical picture similar to sickle cell disease but usually with a milder course.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sickle-Hb E disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> involves coinheritance of the sickle cell gene and hemoglobin E gene. It usually presents with milder symptoms compared to sickle cell anemia but can have clinical variability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle thalassemia often presents with less severe hemolytic anemia compared to sickle cell anemia but has a greater propensity for complications such as retinopathy and aseptic necrosis of bones.</span></span></p>",
      "correct_choice_id": 166842,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}